CRSP — CRISPR Therapeutics AG
In 2026 Q2, 3 of the 140 tracked hedge funds reported a position in CRISPR Therapeutics AG (CRSP), worth $2.19M combined. Over the quarter 3 opened or added, 1 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Quadrature | $1.59M | 0.01% | NEW |
| IMC | $584.07K | 0.00% | NEW |
| Persistent | $11.89K | 0.00% | NEW |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.